Occurrence of giant cell arteritis...suddenly

Transactions of the American Ophthalmological Society

Volumn 105, Issue , 2007, Pages 141-144

  Younge, Brian R ^a   Weyand, Cornelia M ^a,b   Goronzy, Jorg J ^a,b  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD83 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 18; MACROPHAGE INFLAMMATORY PROTEIN 3BETA;

AGED; ANAMNESIS; ARTICLE; BLOOD VESSEL BIOPSY; CASE REPORT; CLINICAL FEATURE; DENDRITIC CELL; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY;

AGED; CORONARY VESSELS; CYTOKINES; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-18; MALE; POLYMYALGIA RHEUMATICA; TEMPORAL ARTERIES; TRANSCRIPTION, GENETIC;

EID: 47749147634     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;3:530-543.
2. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
3. Younge BR, Cook BE Jr, Bartley GB, Hodge DO, Hunder GG. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc 2004;79:483-491 [erratum in Mayo Clin Proc 2004;79:709; Mayo Clin Proc 2004;79:1341].
4. Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 2006;54:3310-3318.